Alzamend Neuro Inc. (ALZN)
undefined
undefined%
At close: undefined
1.19
0.00%
Pre-market Dec 16, 2024, 04:10 AM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -9.95M -14.88M -12.36M -5.05M -4.41M -4.86M -931.66K -1.57M -69.46K
Depreciation & Amortization 50.74K 23.07K 3.55K - - - - - -
Stock-Based Compensation 955.63K 3.58M 4.41M 2.03M 1.80M 396.17K 218.42K 114.41K 40.98K
Other Working Capital 670.67K -1.71M 633.60K -152.45K -299.35K 1.23M -1.35M -49.68K -5.63K
Other Non-Cash Items 714.00 1.71M 8.77K 454.63K 562.28K 2.19M 227.21K 88.47K 15.61K
Deferred Income Tax - -1.71M - - - - - - -
Change in Working Capital 670.67K 2.35M 1.33M -152.45K -299.35K 1.23M -1.35M -49.68K -5.63K
Operating Cash Flow -8.27M -8.92M -6.61M -2.71M -2.35M -1.05M -2.05M -1.42M -18.49K
Capital Expenditures -147.24K - -106.46K - - - - - -
Acquisitions - - - - - - - - -
Purchase of Investments - - 5.37M - - - - - -
Sales Maturities Of Investments - - - - - - - - -
Other Investing Acitivies - - -5.37M 100.92K 105.00K 234.09K -400.00K - -
Investing Cash Flow -147.24K - -106.46K 100.92K 105.00K 234.09K -400.00K - -
Debt Repayment 300.00K - - 400.19K - - -364.10K - -
Common Stock Repurchased - - - - - - - - -
Dividend Paid - - - - - - - - -
Other Financial Acitivies 2.10M 200.00 18.85M 4.05M 2.29M 72.70K -259.41K 1.42M 25.34K
Financial Cash Flow 3.65M 200.00 18.85M 4.45M 2.29M 308.72K 2.99M 1.42M 25.34K
Net Cash Flow -4.76M -8.92M 12.13M 1.84M 47.68K -502.39K 540.02K 3.83K 6.85K
Free Cash Flow -8.42M -8.92M -6.72M -2.71M -2.35M -1.05M -2.05M -1.42M -18.49K